Other current appointments
- Managing Partner at Pureos Bioventures, a venture capital firm specializing in early-stage financing to support innovative young drug development companies, with a focus on Switzerland and Europe, since 2017
- Member of the Board of Directors of Ariceum Therapeutics, Germany, since 2021
- Member of the Board of Directors of River Renal Inc., New York, USA, since 2021
Previous appointments and professional experience
- Member of the Board of Directors of Alentis Therapeutics AG, Basel, until 2024
- Various roles at venture capital firms in Switzerland
Education
- ETH Zurich, postgraduate studies in economics, business administration, and management
- ETH Zurich, Dr. rer. nat. in protein chemistry
- ETH Zurich, degree in natural sciences
